These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 24133386)

  • 1. Advanced ultrasonography technologies to assess the effects of radiofrequency ablation on hepatocellular carcinoma.
    Toshikuni N; Shiroeda H; Ozaki K; Matsue Y; Minato T; Nomura T; Hayashi N; Arisawa T; Tsutsumi M
    Radiol Oncol; 2013; 47(3):224-9. PubMed ID: 24133386
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Use of intra-procedural fusion imaging combining contrast-enhanced ultrasound using a perflubutane-based contrast agent and auto sweep three-dimensional ultrasound for guiding radiofrequency ablation and evaluating its efficacy in patients with hepatocellular carcinoma.
    Sanga K; Numata K; Nihonmatsu H; Ogushi K; Fukuda H; Chuma M; Hashimoto H; Koizumi N; Maeda S
    Int J Hyperthermia; 2020; 37(1):202-211. PubMed ID: 32070164
    [No Abstract]   [Full Text] [Related]  

  • 3. Planning Sonography Using Real-time Virtual Sonography and Contrast-enhanced Sonography for Radiofrequency Ablation of Inconspicuous Hepatocellular Carcinoma Nodules.
    Toshikuni N; Takuma Y; Tomokuni J; Yamamoto H
    Hepatogastroenterology; 2015 May; 62(139):661-6. PubMed ID: 26897949
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pretreatment evaluation with contrast-enhanced ultrasonography for percutaneous radiofrequency ablation of hepatocellular carcinomas with poor conspicuity on conventional ultrasonography.
    Kim AY; Lee MW; Rhim H; Cha DI; Choi D; Kim YS; Lim HK; Cho SW
    Korean J Radiol; 2013; 14(5):754-63. PubMed ID: 24043968
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Efficacy of radiofrequency ablation to treat advanced hepatocellular carcinoma].
    Wu J; Chen MH; Yang W; Wu W; Yan K
    Zhonghua Gan Zang Bing Za Zhi; 2012 Apr; 20(4):256-60. PubMed ID: 22964144
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Usefulness of the hyperechoic rim for assessing the therapeutic efficacy of radiofrequency ablation in hepatocellular carcinoma patients.
    Uehara T; Hirooka M; Kisaka Y; Abe M; Hiasa Y; Onji M
    Hepatol Res; 2009 Oct; 39(10):954-62. PubMed ID: 19624769
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Radiofrequency ablation assisted by real-time virtual sonography for hepatocellular carcinoma inconspicuous under sonography and high-risk locations.
    Lee CH; Chen WT; Lin CC; Teng W; Lin SM; Chiu CT
    Kaohsiung J Med Sci; 2015 Aug; 31(8):413-9. PubMed ID: 26228280
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Feasibility of Extracted-Overlay Fusion Imaging for Intraoperative Treatment Evaluation of Radiofrequency Ablation for Hepatocellular Carcinoma.
    Makino Y; Imai Y; Igura T; Kogita S; Sawai Y; Fukuda K; Iwamoto T; Okabe J; Takamura M; Fujita N; Hori M; Takehara T; Kudo M; Murakami T
    Liver Cancer; 2016 Oct; 5(4):269-279. PubMed ID: 27781199
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Contrast-enhanced sonography with abdominal virtual sonography in monitoring radiofrequency ablation of hepatocellular carcinoma.
    Kisaka Y; Hirooka M; Koizumi Y; Abe M; Matsuura B; Hiasa Y; Onji M
    J Clin Ultrasound; 2010; 38(3):138-44. PubMed ID: 20014137
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Usefulness of contrast-enhanced ultrasonography with abdominal virtual ultrasonography in assessing therapeutic response in hepatocellular carcinoma treated with radiofrequency ablation.
    Kisaka Y; Hirooka M; Kumagi T; Uehara T; Hiasa Y; Kumano S; Tanaka H; Michitaka K; Horiike N; Mochizuki T; Onji M
    Liver Int; 2006 Dec; 26(10):1241-7. PubMed ID: 17105590
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Modified technique for determining therapeutic response to radiofrequency ablation therapy for hepatocellular carcinoma using US-volume system.
    Hiraoka A; Hirooka M; Koizumi Y; Hidaka S; Uehara T; Ichikawa S; Hasebe A; Miyamoto Y; Ninomiya T; Michitaka K; Horiike N; Yamashita Y; Hiasa Y; Matsuura B; Onji M
    Oncol Rep; 2010 Feb; 23(2):493-7. PubMed ID: 20043112
    [TBL] [Abstract][Full Text] [Related]  

  • 12. An Image Fusion System for Estimating the Therapeutic Effects of Radiofrequency Ablation on Hepatocellular Carcinoma.
    Toshikuni N; Matsue Y; Ozaki K; Yamada K; Hayashi N; Tsuchishima M; Tsutsumi M
    Radiol Oncol; 2017 Sep; 51(3):263-269. PubMed ID: 28959162
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Quantitative dynamic contrast-enhanced ultrasound to predict intrahepatic recurrence of hepatocellular carcinoma after radiofrequency ablation: a cohort study.
    Han X; Dong J; Liu Z; Wu B; Tian Y; Tan H; Cheng W
    Int J Hyperthermia; 2020; 37(1):1066-1073. PubMed ID: 32924654
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fusion imaging with contrast-enhanced ultrasonography for evaluating the early therapeutic efficacy of radiofrequency ablation for small hypervascular hepatocellular carcinomas with iso-echoic or unclear margins on conventional ultrasonography.
    Nishigori S; Numata K; Irie K; Fukuda H; Chuma M; Maeda S
    J Med Ultrason (2001); 2018 Jul; 45(3):405-415. PubMed ID: 29362966
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Radiofrequency ablation assisted by real-time virtual sonography and CT for hepatocellular carcinoma undetectable by conventional sonography.
    Nakai M; Sato M; Sahara S; Takasaka I; Kawai N; Minamiguchi H; Tanihata H; Kimura M; Takeuchi N
    Cardiovasc Intervent Radiol; 2009 Jan; 32(1):62-9. PubMed ID: 18987911
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Role of Contrast-enhanced Ultrasound in Guiding Radiofrequency Ablation of Hepatocellular Carcinoma: A Retrospective Study.
    Chan AK; Hegarty C; Klass D; Yoshida E; Chung S; Liu DM; Ho SG; Harris AC
    Can Assoc Radiol J; 2015 May; 66(2):171-8. PubMed ID: 25637354
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Four-dimensional ultrasonography for therapeutic radiofrequency ablation for hepatocellular carcinoma.
    Hotta N; Maeno T; Ayada M; Sato K; Ishikawa T; Okumura A; Matsumoto E; Fukuzawa Y; Kakumu S
    Hepatogastroenterology; 2006; 53(70):521-5. PubMed ID: 16995453
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effectiveness of real-time virtual sonography-guided radiofrequency ablation treatment for patients with hepatocellular carcinomas.
    Kitada T; Murakami T; Kuzushita N; Minamitani K; Nakajo K; Osuga K; Miyoshi E; Nakamura H; Kishino B; Tamura S; Hayashi N
    Hepatol Res; 2008 Jun; 38(6):565-71. PubMed ID: 18218008
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Laparoscopic Contrast-Enhanced Ultrasonography for Real Time Monitoring of Laparoscopic Radiofrequency Ablation for Hepatocellular Carcinoma: an Observational Pilot Study.
    Bartoș A; Bartos D; Spârchez Z; Iancu I; Ciobanu L; Iancu C; Breazu C
    J Gastrointestin Liver Dis; 2019 Dec; 28(4):457-462. PubMed ID: 31826072
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The use of contrast-enhanced ultrasonography in the selection of patients with hepatocellular carcinoma for radio frequency ablation therapy.
    Chen MH; Wu W; Yang W; Dai Y; Gao W; Yin SS; Yan K
    J Ultrasound Med; 2007 Aug; 26(8):1055-63. PubMed ID: 17646367
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.